Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07471048) titled 'A Study to Evaluate the Impact of a Magnolia Officinalis Dietary Supplement on Immune Biomarkers in Subjects With Psoriasis' on March 10.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Basic Science. Masking: Triple (Participant, Investigator, Outcomes Assessor).
Primary Sponsor: Sirt3 LLC
Condition:
Psoriasis
Intervention:
Dietary Supplement: Oral supplement containing 200mg Magnolia officinalis bark extract
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: March 1, 2026
Target Sample Size: 100
Countries of ...